Evidence map›Paper›PMID 39937287›Full record

ArticleDer Nervenarzt2025

[Acceptance of psilocybin-assisted therapy in German-speaking countries].

Nina Hartter, Marvin Däumichen, Christopher Schmidt, Max Wolff, Gerhard Gründer, Henrik Jungaberle

Abstract readEnglish Abstract
In one paragraph

Article in Der Nervenarzt, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nina HartterInstitut für Psychologie, Humboldt-Universität Berlin, Berlin, Deutschland. Nina.hartter@gmail.com.
Marvin DäumichenMIND Foundation, Boxhagenerstr. 78, 12045, Berlin, Deutschland.
Christopher SchmidtMIND Foundation, Boxhagenerstr. 78, 12045, Berlin, Deutschland.
Max WolffMIND Foundation, Boxhagenerstr. 78, 12045, Berlin, Deutschland.
Gerhard GründerZentralinstitut für Seelische Gesundheit, Abteilung für molekulares Neuroimaging, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Deutschland.
Henrik JungaberleMIND Foundation, Boxhagenerstr. 78, 12045, Berlin, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClinical studies with psilocybin in combination with psychotherapy show promising results for the treatment of various mental disorders; however, there still exists a lack of knowledge, rejection and prejudice towards this new form of therapy among doctors, psychotherapists and patients. The aim of this study was to gain a representative impression, as far as possible, of the level of information and attitudes towards the implementation of psilocybin-assisted therapy (PAT) among mental health experts, patients and the general population.

methodsAn online survey was used to collect information on the attitudes and knowledge of 1456 participants and to test the effect of a brief intervention. Results were determined using analyses of variance and regression models.

resultsRegression analyses showed that a higher knowledge score and self-assessed level of knowledge, own treatment experience and also own experience with psychedelics predicted more positive attitudes towards the introduction of PAT, F(8, 1447) = 154.646, p < 0.001, R

conclusionThe results indicate that participants are optimistic about the implementation of PAT. The relationship between knowledge and acceptance was confirmed. The fact that receiving balanced information leads to higher acceptance should be taken into account when educating and reporting on PAT.

Indexed as

Attitude of Health PersonnelHealth Knowledge, Attitudes, PracticeMental DisordersPatient Acceptance of Health CarePsilocybinPsychotherapyAdultAgedCombined Modality TherapyFemaleGermanyHallucinogensHumansMaleMiddle AgedTreatment OutcomeHallucinogensPsilocybinAcceptanceAugmented psychotherapyPsilocybinPsilocybin-assisted therapyPsychedelic therapy

Identifiers

PMID39937287
PMCPMC12586396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.